| WASHINGTON, D.C. – Despite the fact the FDA had “fully approved” Pfizer Inc-BioNTech COVID-19 two-dose injection, marketed as Comirnaty, the drug company has now updated the Centers for Disease Control (CDC) website admitting that it will never be distributed for use. As Liberty Counsel has stated from the beginning, there is no FDA approved COVID shot available. All COVID shots are under Emergency Use Authorization (EUA), which means people have the right to refuse them. The Pfizer update on the CDC website states: “Pfizer received initial FDA BLA license on 8/23/2021 for its COVID-19 vaccine for use in individuals 16 and older (COMIRNATY). At that time, the FDA published a BLA package insert that included the approved new COVID-19 vaccine tradename COMIRNATY and listed 2 new NDCs (0069-1000-03, 0069-1000-02) and images of labels with the new tradename. These NDCs will not be manufactured. Only NDCs for the subsequently BLA approved tris-sucrose formulation will be produced.” Therefore, Pfizer has exclusively been supplying its version of the experimental shot under authorization of emergency use (EUA) and not the FDA “approved” shot. In fact, the FDA previously did a bait and switch by announcing it approved its “first COVID-19 vaccine” in order to push the “vaccine” mandates and protect the Pfizer pharmaceutical company from legal liability. The FDA took just 108 days to review the data before granting the Pfizer-BioNTech COVID-19 shot full approval. The Pfizer injection, on the other hand, is still considered experimental under U.S. law. Instead of admitting this tactic of not intentionally supplying the “FDA approved” Comirnaty, Pfizer labeled this as an inventory issue and previously put this statement on the CDC website: “Pfizer received FDA BLA license on 8/23/2021 for its COVID-19 vaccine for use in individuals 16 and older (COMIRNATY). At that time, the FDA published a BLA package insert that included the approved new COVID-19 vaccine tradename COMIRNATY and listed 2 new NDCs (0069-1000-03, 0069-1000-02) and images of labels with the new tradename. At present, Pfizer does not plan to produce any product with these new NDCs and labels over the next few months while EUA authorized product is still available and being made available for U.S. distribution. As such, the CDC, AMA, and drug compendia may not publish these new codes until Pfizer has determined when the product will be produced with the BLA labels.” |
 |
| On August 23, 2021, the FDA sent a deceptive approval letter to Pfizer regarding the BioNTech injection, Comirnaty. Then the FDA issued another letter for the existing Pfizer shots which confirms they are still under EUA, are not fully approved, and have a liability shield. These deceptive letters helped mislead the public in order to push the agenda “to get shots in every arm” through unlawful mandates. On October 20, 2021, the FDA sent a follow-up letter regarding the original approval to Pfizer pharmaceutical company that stated, “having concluded that revising this EUA is appropriate to protect the public health or safety under section 564(g)(2) of the Act, FDA is reissuing the August 23, 2021 letter of authorization in its entirety with revisions incorporated to authorize for emergency use the administration of a single booster dose of Comirnaty.” On page 7, footnote 13 of that letter, the FDA clearly states, “Although Comirnaty (COVID-19 Vaccine, mRNA) is approved to prevent COVID-19 in individuals 16 years of age and older, there is not sufficient approved vaccine available for distribution to this population in its entirety at the time of issuance of this EUA” (emphasis added). The Pfizer mRNA shot was developed by BioNTech, a German company in partnership with a Chinese Communist Party-aligned company, Fosun Pharmaceutical Group Co. Ltd located in Shanghai. The bio of Chen Qiyu, executive director and co-CEO of Fosun International, states that he is a member of the 13th Shanghai Standing Committee of the Chinese People’s Political Consultative Conference. Chen was awarded the “Best Entrepreneurial Leader” under Golden Kirinbest Hong Kong Stock Value Ranking by Sina Finance, “Shanghai Excellent Constructor of Socialism with Chinese Characteristics from Non-public Sector.” Pfizer also has eight facilities in China, including a research and develop facility in Wuhan. Liberty Counsel Founder and Chairman Mat Staver said, “The FDA, CDC and Big Pharma have continued to provide bad information in order to push these COVID shots. Pfizer never intended to produce a fully approved version of its shot. It was simply a manipulative scheme to deceive people into thinking they had no right to invoke the Emergency Use Authorization law to decline the shots. Now many people have lost their jobs, their health, and some even their lives, as a result of this deception.” Liberty Counsel is a public law firm and a news partner with Wyoming News. |
